Company / SG&A Expense
BIODESIX INC SG&A Expense History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$87.5M
FY2025
5-year range
$50.5M / $87.5M
FY2021-FY2025
Trend
+8.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has increased for 5 consecutive years, from $35M in FY2020 to $88M in FY2025.
Based on SEC 10-K filings.
$88M in FY2025 with a 5-year CAGR of +20.2%.
Increased from $67M to $88M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +12.5%
- 5-Year CAGR
- +20.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- BIODESIX INC's sg&a expense has grown for 5 consecutive years.
- 5-year CAGR of +20.2%, indicating consistent growth.
- In FY2025, sg&a expense increased 8.8% year-over-year.
- Lowest sg&a expense in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -4.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $87.5M | +8.8% |
| FY2024 | $80.5M | +19.4% |
| FY2023 | $67.4M | +9.6% |
| FY2022 | $61.5M | +21.7% |
| FY2021 | $50.5M | +44.9% |
| FY2020 | $34.9M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026